PubMed COVID-19 Clinical Care
971 - 980 of 2645 results found
Dermatomyositis Flare-Up Following the SARS-CoV-2 Vaccine: A Case Report and Literature Review
Description
Dermatomyositis is a rare auto-immune inflammatory myopathy of unknown etiology. Several environmental factors, including vaccines, have been identified as potential triggers in genetically susceptible individuals. Since the beginning of the
Difference in the Dynamics of Antibody Titer between COVID-19 Vaccination and SARS-CoV-2 Infection in Healthcare Workers -A Case Study Based on Long-Term and Dense Measurement of Antibody Titer
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is prevalent worldwide, and effective and safe vaccines against the virus have been developed. Although trends in antibody titers after vaccination and/or SARS-CoV-2 infection have been
Deprioritization of Ongoing Clinical Trials
Description
To be ethical, clinical trials must exhibit a favorable risk-benefit balance at the time of their initiation. However, in some cases, the expected value of a study decreases while the study is ongoing, due to developments outside of the study itself
Do-Not-Resuscitate Orders by COVID-19 Status Throughout the First Year of the Coronavirus Disease 2019 Pandemic
Description
BACKGROUND: At the beginning of the COVID-19 pandemic, it was unclear whether performing cardiopulmonary resuscitation on COVID-19 patients would be effective or increase COVID-19 transmission to health care workers.
Different RT-PCR Protocol used in SARS-Cov2 PCR Laboratory of Mymensingh Medical College, Bangladesh
Description
The novel corona virus (SARS CoV-2) was first detected on Wuhan, China. After that it spread worldwide and has caused many deaths till now. This virus is also known as novel corona virus because of being newly discovered. Scientifically it is named
Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease
Description
Objective Flares of inflammatory bowel disease (IBD) can occur infrequently after vaccination for coronavirus disease 2019 (COVID-19), although the details of this phenomenon are poorly understood. To clarify the possibility of an unfavorable
Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination
Description
CONCLUSION: Our data confirm differential effects of selective versus unselective S1PRMs on T- and B-cell response to SARS-CoV-2 vaccination and suggest association with S1PRM selectivity rather than lymphocyte redistribution.
Developing magnetic barcode bead fluorescence assay for high throughput analyzing humoral responses against multiple SARS-CoV-2 variants
Description
The continuous mutation of SARS-CoV-2 highlights the need for rapid, cost-effective, and high-throughput detection methods. To better analyze the antibody levels against SARS-CoV-2 and its variants in vaccinated or infected subjects, we developed a
Detection of patients with COVID-19 by the emergency medical services in Lombardy through an operator-based interview and machine learning models
Description
CONCLUSION: ML-based models might help EMS identify patients with SARS-CoV-2 infection, and in guiding EMS allocation of hospital resources based on prespecified criteria.
